By Editor , 13 September 2026
Stafford Launches USDA/FDA-Approved Shaft Collar Line for Food Conveyors

Wilmington, Massachusetts – – September 13, 2026 -- Stafford Manufacturing Corp. has released a full line of shaft collars, couplings, and flange mounts engineered specifically for conveyor and packaging equipment in the food and beverage sector, targeting operators that require frequent wash-down cycles under USDA and FDA compliance standards.

By Editor , 13 September 2026
Chariot Defense Names Ex-Pentagon Officials to Advisory Board

San Bruno, Calif. – September 13, 2026 -- Chariot Defense, a maker of software-defined power distribution systems for the battlefield, has appointed four defense and venture capital veterans to its Board of Advisors, following a $34 million Series A round led by Andreessen Horowitz and a $7.4 million contract with the Pentagon's Department of War Innovation Unit (DIU).

By Editor , 13 September 2026
Hermeus Develops Ramjet-X to Cut High-Mach Flight Test Costs

Los Angeles – September 13, 2026 -- Hermeus is developing Ramjet-X, an expendable, ramjet-powered test vehicle designed to be launched from its reusable Quarterhorse aircraft, aiming to make high-Mach airbreathing flight testing cheaper and more repeatable.

By Editor , 13 September 2026
Sorenson Names Scott Cederbaum Head of Marketing

Salt Lake City – September 12, 2026 -- Sorenson has appointed Scott Cederbaum as Head of Marketing, effective August 10, 2026, tasking him with leading the company's global brand, demand generation and customer lifecycle strategy as accessibility technology and AI converge.

By Editor , 13 September 2026

Taipei – September 12, 2026 -- HanchorBio Inc. (TWSE: 7827) said the U.S. Food and Drug Administration has cleared its HCB101 Single-Patient Expanded Access Protocol (HCB101-EA-001) as "safe to proceed," allowing a Phase 1 patient who showed clinical benefit to continue receiving the investigational drug beyond the parent trial.

By Editor , 13 September 2026
IDEAYA, Servier Dose First Patient in Phase 3 Uveal Melanoma Trial

South San Francisco, Calif. – September 12, 2026 -- IDEAYA Biosciences and Servier have dosed the first patient in OptimUM-11, a global Phase 3 trial testing darovasertib combined with crizotinib as adjuvant therapy for primary uveal melanoma, targeting a disease segment with no approved systemic treatment options.

By Editor , 13 September 2026
NetAlly Launches LinkRunner 100G Tester at $8,999 for Enterprise Fiber

Colorado Springs, Colo. – September 12, 2026 -- NetAlly has launched LinkRunner 100G, a handheld diagnostic tool priced at $8,999 plus an AllyCare Pro subscription, designed to troubleshoot 100G fiber links now spreading from data centers into enterprise networks.

By Editor , 13 September 2026
ERPVAR, Crawford Software Ally to Chase 30% ERP Pipeline Growth

Mission Viejo, Calif. – – September 12, 2026 -- ERPVAR has signed a lead-generation partnership with Crawford Software aimed at driving a 30% increase in qualified sales pipeline for mid-market companies migrating off QuickBooks and other legacy platforms.

By Editor , 13 September 2026
7 Billion Male Chicks Culled Yearly as In-Ovo Sexing Tech Advances

Los Angeles – September 12, 2026 -- An estimated 7 billion male chicks are killed globally each year, roughly 200 every second, as the egg industry continues routine chick culling despite the commercial availability of in-ovo sexing technology, according to a new investigation released by Mercy For Animals.

By Editor , 13 September 2026
Silent Push 6.1 Automates Brand Impersonation Hunting for Enterprises

Reston, Va. – September 12, 2026 -- Silent Push has launched version 6.1 of its preemptive cyber defense platform, introducing a fully automated Brand and Infrastructure Impersonation engine that continuously hunts look-alike domains before they are weaponized in phishing campaigns.